A detailed history of Lazard Asset Management LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 12,104 shares of MRSN stock, worth $5,567. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,104
Holding current value
$5,567
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$1.42 - $2.68 $17,187 - $32,438
12,104 New
12,104 $17,000
Q1 2023

May 15, 2023

BUY
$4.0 - $7.02 $43,284 - $75,963
10,821 New
10,821 $44,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $44.7M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.